Stockscreener 앱 받기
1.1161
0.21%
-0.0039
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharmaceuticals (INO) price target decreased by 12.21% to 6.90 - MSN
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals proposes securities offering - MSN
Inovio prices $17.5 million public offering of shares and warrants - MSN
Inovio Pharmaceuticals Inc (HAM:GBM) Stock Price, Trades & News - GuruFocus
Inovio Pharmaceuticals, Inc. (INO) Presents at World Federation of Hemophilia World CongressSlideshow - Seeking Alpha
INO Forecast, Price Target & Analyst Ratings | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharmaceuticals Q1 2025 Earnings Preview - MSN
Here's why Inovio (INO) looks ripe for bottom fishing - MSN
Inovio Pharmaceuticals (INO) Profitability Outlook | Q4 2025: EPS Beats ForecastsCommunity Buy Signals - Cổng thông tin điện tử tỉnh Lào Cai
INO (Inovio Pharmaceuticals) notches massive Q4 2025 EPS beat, but steep year-over-year revenue drop drags on share price.Trending Buy Opportunities - Xã Thanh Hà
What's going on with Inovio Pharmaceuticals stock on Tuesday? - MSN
NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program - TradingView
INOVIO Pharmaceuticals advances DNA medicines for Hemophilia A and rare disease treatment - Traders Union
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock rises Tuesday, still underperforms market - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Q4 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q3 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Q2 2025 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $6 - Moomoo
INOVIO to Present Hemophilia Research at Global Conference - MyChesCo
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Investor Alert: Deadline in Lawsuit on April 07, 2026 - openPR.com
INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - Sahm
2.17%
자본화:
|
볼륨(24시간):